European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:
“Check out the trials in gynaecological cancers presented at ESTRO24, featuring immunotherapy in cervical cancer, SBRT for oligometastatic cases, and reirradiation insights.”
Source: ESTRO/LinkedIn
Other posts featuring ESTRO on OncoDaily.